Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U5E small nuclear 3, pseudogene (RNU5E-3P) refers to a **pseudogene** related to the U5 small nuclear RNA (snRNA) gene family. U5 snRNAs are components of the U5 small nuclear ribonucleoprotein (snRNP), a core part of the **spliceosome** complex, which is essential for pre-mRNA splicing in eukaryotic cells. However, pseudogenes such as RNU5E-3P are annotated as non-functional sequences; they are considered unexpressed genomic remnants with no documented biological activity or role in disease. The vast majority of snRNA-pseudogenes are not thought to generate any functional product, and their clinical or therapeutic significance remains unconfirmed[3][4]. RNU5E-3P should not be considered a therapeutic target, as it lacks protein-coding ability and direct functional relevance. **Notes:** - RNU5E-3P is not an active receptor, enzyme, transporter, or other typical drug target. - It is a member of the pseudogene class, which by definition typically lacks function and is not targeted by drugs. - Information for U5 functional family members (such as RNU5B-1, RNU5A-1) does not extend to pseudogenes[3][4]. - There is no evidence that RNU5E-3P is involved in disease or serves as a biomarker or therapeutic target. - This entry is primarily relevant for genomic annotation and is often excluded from structured drug target databases. **Summary:** RNU5E-3P (RNA, U5E small nuclear 3, pseudogene) is a nonfunctional pseudogene and is not considered a therapeutic target[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U5E small nuclear 3, pseudogene (RNU5E-3P).